Articles | Volume 11, issue 3
https://doi.org/10.5194/jbji-11-343-2026
https://doi.org/10.5194/jbji-11-343-2026
Review
 | 
12 Jun 2026
Review |  | 12 Jun 2026

Intrawound vancomycin powder in orthopaedic surgery after the VPIP trial: a critical reappraisal of efficacy, dosing, application plane, and antimicrobial stewardship

Felix Werneburg, Alexander Zeh, Natalia Gutteck, and Karl-Stefan Delank

Viewed

Total article views: 34 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
24 9 1 34 0 0
  • HTML: 24
  • PDF: 9
  • XML: 1
  • Total: 34
  • BibTeX: 0
  • EndNote: 0
Views and downloads (calculated since 12 Jun 2026)
Cumulative views and downloads (calculated since 12 Jun 2026)

Viewed (geographical distribution)

Total article views: 7 (including HTML, PDF, and XML) Thereof 7 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 07 Jul 2026
Download
Short summary
For over a decade, orthopaedic surgeons have sprinkled vancomycin powder into surgical wounds to prevent infection. New large randomised trials show this is ineffective in hip and knee replacements, though possibly useful in high-risk fracture surgery and infected revision cases. Based on these findings and international guidelines, we propose a framework that identifies specifically in which operations this antibiotic powder may still have a role and in which it should be avoided.
Share